TD Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-12,664
| Closed | -$803K | – | 1409 |
|
|
2016
Q4 | $803K | Sell |
12,664
-2,404
| -16% | -$152K | ﹤0.01% | 1066 |
|
|
2016
Q3 | $959K | Sell |
15,068
-161
| -1% | -$10.2K | ﹤0.01% | 1020 |
|
|
2016
Q2 | $1.13M | Sell |
15,229
-160
| -1% | -$11.9K | ﹤0.01% | 942 |
|
|
2016
Q1 | $1.03M | Sell |
15,389
-801
| -5% | -$53.5K | ﹤0.01% | 956 |
|
|
2015
Q4 | $1.1M | Hold |
16,190
| – | – | ﹤0.01% | 938 |
|
|
2015
Q3 | $865K | Buy |
16,190
+320
| +2% | +$17.1K | ﹤0.01% | 952 |
|
|
2015
Q2 | $999K | Buy |
+15,870
| New | +$999K | ﹤0.01% | 956 |
|